idazoxan has been researched along with vasoactive intestinal peptide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chariot, J; Presset, O; Rozé, C; Souli, A; Tsocas, A | 1 |
| Bornstein, JC; Foong, JP; Gwynne, RM; Parry, LJ | 1 |
2 other study(ies) available for idazoxan and vasoactive intestinal peptide
| Article | Year |
|---|---|
Neural mechanism of the antisecretory effect of peptide YY in the rat colon in vivo.
Topics: Adrenergic alpha-Antagonists; Animals; Body Water; Colon; Dopamine Antagonists; Dose-Response Relationship, Drug; Haloperidol; Hexamethonium; Idazoxan; Intestinal Mucosa; Jejunum; Male; Nicotinic Antagonists; Peptide YY; Rats; Rats, Wistar; Sodium Channel Blockers; Tetrodotoxin; Vasoactive Intestinal Peptide | 2000 |
5-HT(1A), SST(1), and SST(2) receptors mediate inhibitory postsynaptic potentials in the submucous plexus of the guinea pig ileum.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Electric Stimulation; Excitatory Postsynaptic Potentials; Female; Gene Expression; Guinea Pigs; Idazoxan; Ileum; Inhibitory Postsynaptic Potentials; Lysine; Male; Myenteric Plexus; Neurons; Norepinephrine; Oligopeptides; Piperazines; Quinolines; Receptor, Serotonin, 5-HT1A; Receptors, Somatostatin; Serotonin; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT1 Receptor Antagonists; Serotonin Receptor Agonists; Somatostatin; Submucous Plexus; Vasoactive Intestinal Peptide | 2010 |